Supply Chain Council of European Union | Scceu.org
Distribution

Eli Lilly Pocketed $60M Meant For Medicaid, Ill. Jury Hears

by scceu0389

By Lauraann Wood (July 22, 2022, 9:36 PM EDT) — Eli Lilly and Co. defrauded the federal government of $60 million by deliberately leaving retroactive drug price increases out of the metrics it was required to include for Medicaid rebate calculations, an Illinois federal jury heard Friday.

Eli Lily knowingly failed to pay the government its proper cut of more than $500 million it pocketed in clawbacks from drug wholesalers between 2005 and 2017 by intentionally failing to report its retroactive price increases for the “average manufacturer price” metric that determined Medicaid’s amount under a 30-year-old drug rebate program, counsel for relator Ronald Streck told the jury during opening statements….

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Related posts

Distribution Inventory Management Software Market 2020: Potential Growth, Challenges, and Know the Companies List Could Potentially Benefit or Loose out From the Impact of COVID-19 | Key Players: Pomodo, SAP, Oracle, EVS, Noguska, etc.

scceu

OptiBiotix Health PLC seals distribution deal for LPLDL in the USA and Canada

scceu

Johnson and Johnson vaccine could be key to the distribution slowdown

scceu